A Study of Ocrelizumab in Comparison with Interferon Beta 1a (Rebif) in Patients with Relapsing Multiple Sclerosis ClinicalTrials.gov, 27 Jan 2012 Accessed on 20 Feb 2012 from http://clinicaltrials.gov/ct2/show/NCT01412333. CommentRecommendBookmarkWatch